Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Savient falls after analyst downgrades stock, expecting lower sales of its gout drug Krystexxa
Savient falls after analyst downgrades stock, expecting lower sales of its gout drug Krystexxa
Savient falls after analyst downgrades stock, expecting lower sales of its gout drug Krystexxa
Submitted by
admin
on November 11, 2011 - 9:50am
Source:
Yahoo/AP
News Tags:
Savient
gout
Krystexxa
Headline:
Savient falls after analyst downgrades stock, expecting lower sales of its gout drug Krystexxa
Do Not Allow Advertisers to Use My Personal information
